TRIAMTERENE AND RENAL STONES

JICK, HERSHEL
DINAN, BARBARA J.
HUNTER, JUDITH R.

From the Boston Collaborative Drug Surveillance Program, Boston University Medical Center, Waltham, Massachusetts
Group Health Cooperative of Puget Sound, Seattle, Washington

Accepted for publication May 8, 1981.

Supported by Grant FD01009 from the Food and Drug Administration, and Smith, Kline and French Laboratories.

^*Requests for reprints: Boston Collaborative Drug Surveillance Program, 400-1 Totten Pond Rd., Waltham, Massachusetts 02154.

Journal of Urology 127(2):p 224-225, February 1982. | DOI: 10.1016/S0022-5347(17)53708-8

The frequency of hospitalization for renal stones was similar for recipients of triamterene, hydrochlorothiazide (alone), thyroid and diazepam among members of a large prepaid health maintenance organization. In 4 triamterene recipients in whom analysis of the stone was done no triamterene was found.